NRS Journal Club - Bronchopulmonary Dysplasia
These materials are only intended for those that attended the NRS Journal Club, held on January 27, 2023.
Best practices in neonatal care aim to ensure the survival and healthy development of the infant, and improved awareness of these practices can positively impact multiple aspects of care, including diagnostic and management strategies, evaluative assessments of high-risk newborns and treatment approaches for neonates requiring NICU care. This series of journal club activities will provide a venue for neonatal health care practitioners to stay current with best practices identified within recent medical literature and to identify, describe and disseminate effective clinical strategies that can improve the standards of neonatal care provided by the health care team.
Bronchopulmonary dysplasia (BPD), which causes respiratory illness in 30% to 50% of preterm newborns, is associated with significant morbidity, mortality and an increased risk for poor medical and developmental outcomes throughout childhood. This journal club activity will examine current research on the treatment-based classification of BPD severity and its ability to accurately predict respiratory morbidity and death. It will also discuss an updated, online BPD outcome estimator tool that evaluates the risk of developing BPD and/or death within the first month after birth.
Articles Reviewed in This Journal Club:
1. Greenberg RG, McDonald SA, Laughon MM, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Online clinical tool to estimate risk of bronchopulmonary dysplasia in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed. 2022 Jun 21:fetalneonatal-2021-323573. doi:10.1136/archdischild-2021-323573
2. Jensen EA, Dysart K, Gantz MG, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019;200(6):751-759. doi:10.1164/rccm.201812-2348OC
1. National Heart, Lung, and Blood Institute. Bronchopulmonary dysplasia (BPD). March 24, 2022. Accessed January 10, 2023. https://www.nhlbi.nih.gov/health/bronchopulmonary-dysplasia
2. Gilfillan M, Bhandari A, Bhandari V. Diagnosis and management of bronchopulmonary dysplasia. BMJ. 2021;375:n1974. doi:10.1136/bmj.n1974
3. World Health Organization. WHO stresses the importance of neonatal best practices for a healthy start to life. October 25, 2016. Accessed January 10, 2023. https://www.who.int/westernpacific/news/item/25-10-2016-who-stresses-the-importance-of-neonatal-best-practices-for-a-healthy-start-to-life
This activity is jointly provided by Optum Health Education and Optum Health Solutions.
There was no commercial support received for this activity.
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
This activity is designed to meet the educational needs of physicians who have an interest in neonatal care.
At the end of this educational activity, participants should be able to:
- Discuss the limitations of current diagnostic criteria for BPD in preterm infants.
- Identify how to estimate the probability of BPD or death in preterm infants with reasonable accuracy using an updated BPD outcome estimator tool.
- Describe risk factors for BPD and how underlying risks can influence treatment effectiveness.
- Discuss BPD diagnostic criteria that best predict the likelihood of respiratory morbidity or death.
Jamie Rosterman, DO
National Medical Director, Neonatal Resource Services | Optum Health Solutions
Elizabeth Albert, MD
Clinical Activity Manager
Optum Health Education
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Optum Health Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
The activity faculty or planners have no financial relationships to disclose.
In support of improving patient care, this activity has been planned and implemented by Optum Health Education and Optum Health Solutions. Optum Health Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit designation statements
Optum Health Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been pre-approved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.
- 1.00 AMA - Physicians
- 1.00 Attendance - General Attendance
You must be logged into your account to participate in this activity. Get started by completing the “Evaluation”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”